famotidine has been researched along with Cytomegalovirus Infections in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Cytomegalovirus Infections: Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshinaga, M | 1 |
| Nakate, S | 1 |
| Motomura, S | 1 |
| Sugimura, T | 1 |
| Sasaki, I | 1 |
| Tsuneyoshi, M | 1 |
1 other study available for famotidine and Cytomegalovirus Infections
| Article | Year |
|---|---|
Cytomegalovirus-associated gastric ulcerations in a normal host.
Topics: Adult; Cytomegalovirus Infections; Famotidine; Humans; Inclusion Bodies, Viral; Male; Stomach; Stoma | 1994 |